CDLX - Company ID 0001666071
The table below shows Cardlytics, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $9.29M | -$8.82M | -$185.00K | -$53.90M | -$38.52M | -$7.60M |
| Capital expenditure | $480.00K | $1.56M | $667.00K | $1.17M | $3.11M | $5.41M |
| Investing cash flow | -$15.30M | -$18.75M | -$10.06M | -$15.76M | -$506.69M | -$10.12M |
| Dividends paid | - | - | - | - |
Cardlytics, Inc. reported operating cash flow of $9.29M for fiscal year 2025. That is up 205.3% from -$8.82M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$32.50M (FY 2016) to $9.29M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | $0.00 | $0.00 | $40.00M | $0.00 | $0.00 |
| Financing cash flow | -$11.12M | $1.44M | -$20.03M | -$39.99M | $486.00M | $206.43M |